tiprankstipranks
Enlivex Therapeutics Ltd (ENLV)
NASDAQ:ENLV
US Market
Want to see ENLV full AI Analyst Report?

Enlivex (ENLV) Stock Forecast & Price Target

563 Followers
See the Price Targets and Ratings of:

ENLV Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Enlivex
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ENLV Stock 12 Month Forecast

There Are No Analyst Ratings for ENLV In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

ENLV Financial Forecast

ENLV Earnings Forecast

The previous quarter’s earnings for ENLV were -$0.02.
The previous quarter’s earnings for ENLV were -$0.02.
No data currently available

ENLV Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on ENLV
H.C. Wainwright
H.C. Wainwright
$13$20
Buy
2225.58%
Upside
Reiterated
04/07/26
Analysts Offer Insights on Healthcare Companies: Enlivex (NASDAQ: ENLV) and Sanofi (Other OTC: SNYNF)
D. Boral Capital Analyst forecast on ENLV
D. Boral Capital
D. Boral Capital
Hold
Downgraded
11/24/25
Enlivex Therapeutics downgraded to Hold from Buy at D. Boral CapitalEnlivex Therapeutics downgraded to Hold from Buy at D. Boral Capital
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on ENLV
H.C. Wainwright
H.C. Wainwright
$13$20
Buy
2225.58%
Upside
Reiterated
04/07/26
Analysts Offer Insights on Healthcare Companies: Enlivex (NASDAQ: ENLV) and Sanofi (Other OTC: SNYNF)
D. Boral Capital Analyst forecast on ENLV
D. Boral Capital
D. Boral Capital
Hold
Downgraded
11/24/25
Enlivex Therapeutics downgraded to Hold from Buy at D. Boral CapitalEnlivex Therapeutics downgraded to Hold from Buy at D. Boral Capital
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Enlivex

3 Months
Ram SelvarajuH.C. Wainwright
Success Rate
3/5 ratings generated profit
60%
Average Return
-4.52%
Copying Ram Selvaraju's trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of -4.52% per trade.
1 Year
Ram SelvarajuH.C. Wainwright
Success Rate
0/5 ratings generated profit
0%
Average Return
-28.26%
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -28.26% per trade.
2 Years
Ram SelvarajuH.C. Wainwright
Success Rate
0/5 ratings generated profit
0%
Average Return
-45.22%
Copying Ram Selvaraju's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -45.22% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ENLV Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
1
1
1
1
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
1
1
1
0
In the current month, ENLV has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ENLV average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

ENLV Stock Forecast FAQ

What is ENLV’s average 12-month price target, according to analysts?
Currently, no data Available
What is ENLV’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for ENLV, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is ENLV a Buy, Sell or Hold?
      Currently, no data Available
      What is Enlivex Therapeutics Ltd’s price target?
      Currently, no data Available
      What do analysts say about Enlivex Therapeutics Ltd?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of ENLV?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.